Shares of Fevertree Drinks PLC (LON:FEVR) have been assigned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is GBX 3,730 ($48.74).
FEVR has been the subject of a number of analyst reports. Berenberg Bank upped their price objective on shares of Fevertree Drinks from GBX 3,350 ($43.77) to GBX 4,250 ($55.53) and gave the company a “buy” rating in a research report on Friday, October 5th. Deutsche Bank decreased their price objective on shares of Fevertree Drinks from GBX 3,000 ($39.20) to GBX 2,600 ($33.97) and set a “hold” rating for the company in a research report on Thursday, December 13th.
Fevertree Drinks stock traded up GBX 2 ($0.03) during trading on Friday, reaching GBX 2,513 ($32.84). 442,043 shares of the company’s stock were exchanged, compared to its average volume of 460,543. Fevertree Drinks has a 52-week low of GBX 1,353.93 ($17.69) and a 52-week high of GBX 2,926 ($38.23).
Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, aromatic tonic water, Clementine tonic water, lemon tonic water, ginger beer, ginger ale, Madagascan cola, Sicilian lemonade, lemonade, and spring soda water.
Featured Article: Balanced Fund
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.